Travel & Leisure
Tazeen Ahmad Maintained (BCRX) at Sell with Decreased Target to $8 on, Dec 4th, 2014
Tazeen Ahmad of B of A Securities, Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Sell with Decreased Target from $9 to $8 on, Dec 4th, 2014.
Tazeen has made no other calls on BCRX in the last 4 months.
There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, 0 agree with Tazeen's Rating of Hold.
This is the rating of the analyst that currently disagrees with Tazeen
- Jessica Fye of "JP Morgan" Initiated at Buy and Held Target at $20 on, Friday, August 8th, 2014
Similar Travel and Leisure Articles
[ Tue, Dec 02nd 2014
] - WOPRAI
[ Tue, Nov 18th 2014
] - WOPRAI
[ Thu, Sep 18th 2014
] - WOPRAI
[ Thu, Sep 04th 2014
] - WOPRAI
[ Wed, Aug 13th 2014
] - WOPRAI
[ Thu, Jul 31st 2014
] - WOPRAI
[ Thu, Apr 17th 2014
] - WOPRAI
[ Mon, Mar 10th 2014
] - WOPRAI
[ Tue, Feb 11th 2014
] - WOPRAI
[ Tue, Dec 31st 2013
] - WOPRAI
[ Wed, Nov 06th 2013
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI